ELV - NYSE
Elevance Health Inc.
$391.27
-2.8%Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
At a Glance
Live SnapshotElevance Health Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
CapEx Intensity
Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extension—monitor closely.
Cash Flow Quality Insight
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
Elevance Health Inc. Cash Flow Statement
ELV • NYSE
| Elevance Health Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
5.7B | 6B | 6B | 6B | 6.1B | 4.6B | 4.8B | 3.8B | 3.8B | 2.5B | 2.6B | 2.6B | 2.7B | 2.7B | 2.6B | 2.9B | 4.7B | 2.5B | 3.3B | 3.1B | |
1.5B | 1.4B | 1.7B | 1.7B | 1.3B | 1.2B | 1.1B | 1.1B | 890.4M | 911.8M | 907.9M | 851M | 908.8M | 740.7M | 637.2M | 103.1M | 107.1M | 105.4M | 586.2M | 604.9M | |
-279M | -374M | -602M | -76M | 173M | -540M | 81M | 91M | -1.3B | 126.9M | -65.9M | 30.7M | 59.1M | 127.5M | 74.3M | 101.8M | 61.3M | -481.4M | -105.5M | 273.7M | |
276M | 191M | 289M | 264M | 255M | 283M | 294M | 226M | 169.6M | 164.6M | 148.2M | 168.9M | 146M | 146.5M | 134.8M | 136M | 153.6M | 156M | 177.1M | 246.9M | |
363M | 346M | 1.2B | 264M | -245M | 16M | -62M | 235M | 186.2M | 106.3M | -161.4M | -87.1M | -6.2M | -254.4M | -180.7M | 433.2M | -2.7B | 1.8B | -153.2M | -134.5M | |
-3.3B | -1.7B | -535M | 253M | 784M | 5.2B | -192M | -1.6B | 367.9M | -574.9M | 727.2M | -160.7M | -766.9M | -671.2M | 62.1M | -2.2B | 653.8M | -1.5B | 494.6M | -41.7M | |
4.3B | 5.8B | 8.1B | 8.4B | 8.4B | 10.7B | 6.1B | 3.8B | 4.2B | 3.2B | 4.1B | 3.4B | 3.1B | 2.7B | 3.4B | 1.4B | 3B | 2.5B | 4.3B | 4B | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-1.1B | -1.3B | -1.3B | -1.2B | -1.1B | -1B | -1.1B | -1.2B | -790.2M | -583.6M | -602.9M | -626.6M | -607.3M | -544.9M | -519.5M | -451.4M | -378.4M | -345.6M | -322M | -193.9M | |
(88M) | -4.4B | -1.6B | -649M | -3.5B | -2B | (0.0) | -1.8B | -2.1B | (0.0) | -638.9M | (740M) | (0.0) | -4.6B | -600M | -300K | (4.6B) | -192.7M | -298.5M | -25.4M | |
-15B | -18B | -16.2B | -24.9B | -18.7B | -19.5B | -23B | -9.7B | -16.4B | -12.1B | -11.9B | -10.8B | -14.9B | -15.6B | -12.5B | -11B | -7.6B | -7B | -9.9B | -13.6B | |
15.1B | 18.6B | 13.5B | 22.6B | 14.6B | 16.1B | 21B | 11.6B | 13.5B | 12B | 11.8B | 10.3B | 13.7B | 15.9B | 12.7B | 10.8B | 6.2B | 7.9B | 9.7B | 13.3B | |
-385M | -51M | -24M | -421M | -1B | -894M | 204M | -220M | 636.4M | 219M | 206.2M | -545.7M | -403.8M | 311.4M | 1.5M | -579.5M | 100.8M | 225.6M | 13.7M | 91.9M | |
-1.3B | -5.2B | -5.6B | -4.6B | -9.6B | -7.3B | -2.8B | -1.3B | -5.1B | -513.9M | -1.2B | -974.9M | -2.2B | -4.6B | -942M | -1.3B | (3B) | (616.2M) | -768.9M | -457.3M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-2.6B | -2.9B | -2.7B | -2.3B | -1.9B | -2.7B | -1.7B | -435M | -2B | -67M | -1.5B | -3B | -1.6B | -2.5B | -3B | -4.4B | -2.6B | -3.3B | -6.2B | -4B | |
2.3B | 5.6B | 739M | 1.8B | 2.3B | 188M | 608M | -849M | 3.7B | 360M | -892.3M | 763.7M | -583.7M | 5.1B | 1.1B | 514.4M | -768.1M | -271.5M | 1.8B | 614.4M | |
-1.5B | -1.5B | -1.4B | -1.2B | -1.1B | -954M | -818M | -776M | -704.9M | -684M | -656.6M | -480.7M | -448M | -367.1M | -357.8M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-2.6B | -2.9B | -2.7B | -2.3B | -1.9B | -2.7B | -1.7B | -1.7B | -2B | -67M | -1.5B | -3B | -1.6B | -2.5B | -3B | -4.4B | -2.6B | -3.3B | -6.2B | -4.6B | |
69M | 39M | -17M | 432M | 1.1B | 899M | -271M | -355M | -820.7M | -408.9M | 67.3M | 893.3M | 934M | -168.2M | 258.2M | 676.6M | 3.7M | -187.9M | 937.8M | -348.7M | |
-1.7B | 1.2B | -3.3B | -1.3B | 423M | -2.6B | -2.3B | -2.2B | 426.9M | -732.9M | -3B | -1.8B | -1.7B | 2.1B | -2B | -3.2B | -3.4B | -3.7B | -3.4B | -3.7B | |
CASH FLOW SUMMARY | ||||||||||||||||||||
-5M | -72M | -1M | -14M | -10M | 7M | 0.0 | -2M | 4.3M | 4.1M | -5.3M | -7.1M | 2.2M | 1.1M | -400K | -3.2M | -6.7M | 0.0 | 0.0 | 0.0 | |
1.2B | 1.8B | -861M | 2.5B | -861M | 804M | 1B | 325M | -466.4M | 2B | -38.2M | 564.8M | -897.7M | 283M | 412.8M | -3B | 2.6B | -584M | 165.8M | -138.1M | |
8.3B | 6.5B | 7.4B | 4.9B | 5.7B | 4.9B | 3.9B | 3.6B | 4.1B | 2.1B | 2.2B | 1.6B | 2.5B | 2.2B | 1.8B | 4.8B | 2.2B | 2.8B | 2.6B | 2.7B | |
9.5B | 8.3B | 6.5B | 7.4B | 4.9B | 5.7B | 4.9B | 3.9B | 3.6B | 4.1B | 2.1B | 2.2B | 1.6B | 2.5B | 2.2B | 1.8B | 4.8B | 2.2B | 2.8B | 2.6B | |
3.2B | 4.6B | 6.8B | 7.2B | 7.3B | 9.7B | 5B | 2.6B | 3.4B | 2.6B | 3.5B | 2.7B | 2.4B | 2.2B | 2.9B | 965.3M | 2.7B | 2.2B | 4B | 3.9B |
SEC Filings
ELV - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 13, 2026 | May 13, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 22, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 22, 2026 | April 22, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 27, 2026 | May 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 10, 2026 | March 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | March 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 06, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | January 28, 2026 | January 28, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 10, 2025 | December 10, 2025 | 2025 |
Related Guides
Continue your ELV research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.